Protalix Biotherapeutics, Inc. (PLX)

1.755 +0.02 (+0.86%) USD  |  NYAM  |  Dec 31, 11:24
More

Protalix Biotherapeutics Net Non-Operating Interest Income Expense (Quarterly)

Net Non-Operating Interest Income Expense (Quarterly) Chart

View Net Non-Operating Interest Income Expense (Quarterly) for PLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Non-Operating Interest Income Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years

View Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Non-Operating Interest Income Expense (Quarterly) Benchmarks

View Net Non-Operating Interest Income Expense (Quarterly) Benchmarks
Start Trial
PAVmed, Inc. Upgrade
Denali Therapeutics, Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade
Perspective Therapeutics, Inc. Upgrade
Armata Pharmaceuticals, Inc. Upgrade